Pharma Deals Review, Vol 2008, No 94 (2008)

Font Size:  Small  Medium  Large

EUSA Pharma to Acquire Cytogen

Business Review Editor

Abstract


EUSA Pharma entered into a definitive agreement to acquire Cytogen for US$22.6 M in cash at a price of US$0.62 per share.

Full Text: pdf

Add comment

Creative Commons License
This work is licensed under a Creative Commons Attribution 3.0 License.